Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENALIDOMIDE vs LETROZOLE\RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENALIDOMIDE vs LETROZOLE\RIBOCICLIB: Safety Overview

Metric LENALIDOMIDE LETROZOLE\RIBOCICLIB
Total FAERS Reports 349,955 621
Deaths Reported 35,942 78
Death Rate 10.3% 12.6%
Hospitalizations 86,495 80
Average Patient Age 69.9 yrs 64.2 yrs
% Female Patients 50.0% 98.2%
FDA Approval Date Aug 3, 2023 N/A
Manufacturer Padagis US LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A